| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T440 |
0-20 |
Sentence |
denotes |
Question 5 statement |
| T441 |
21-174 |
Sentence |
denotes |
So far, no definitive efficacy or effectiveness data are available on the benefit of corticosteroid administration in patients with SARS-CoV-2 infection. |
| T442 |
175-341 |
Sentence |
denotes |
As the World Health Organization underlines, there is an important need for efficacy data from RCT for supporting corticosteroids therapy in patients with SARS-CoV-2. |
| T443 |
342-803 |
Sentence |
denotes |
However, considering that overwhelming inflammation and cytokine-related lung injury might be responsible for the rapidly progressive pneumonia and clinical deterioration in COVID-19 patients [44,58,67], we suggest (expert opinion only) to consider administration of corticosteroids in critically ill COVID-19 patients with ARDS or with worsening of non-ARDS respiratory failure in the absence of bacterial/fungal superinfections (independent of ICU admission). |
| T444 |
804-1032 |
Sentence |
denotes |
However, in the absence of convincing evidence, the following cannot currently be supported: steroid administration stratified according to inflammatory markers and steroid administration in non–critically ill COVID-19 patients. |
